Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
RESEARCH TOOLSreports
Bolt Biotherapeutics (BOLT) Ownership - Who Owns Bolt Biotherapeutics?
183 Followers
Bolt Biotherapeutics (BOLT) Ownership Overview
43.52% Insiders
3.81% Mutual Funds
12.20% Other Institutional Investors
40.46% Public Companies and
Individual Investors
The ownership structure of Bolt Biotherapeutics (BOLT) stock is a mix of institutional, retail and individual investors. Approximately 16.01% of the company’s stock is owned by Institutional Investors, 43.52% is owned by Insiders and 40.46% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 13, 2023 | Bought | $7125 | |
| Dec 01, 2023 | Edgar Engleman Director | Sold | $127842 |
| Nov 22, 2023 | Edgar Engleman Director | Sold | $1749 |
| Nov 22, 2023 | Vivo Capital Viii, Llc >10% Owner | Sold | $3060 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,018,671 | Institution | 2.67% | 1,130,725 | |
| 912,197 | Institution | 2.39% | 1,012,539 | |
| 415,039 | Institution | 1.09% | 460,693 | |
| 321,840 | Institution | 0.84% | 357,242 | |
| 111,200 | Institution | 0.29% | 123,432 | |
| 56,323 | Institution | 0.15% | 62,519 | |
| 56,143 | Institution | 0.15% | 62,319 | |
| 50,695 | Institution | 0.13% | 56,271 | |
| 28,500 | Institution | 0.07% | 31,635 | |
| 18,932 | Institution | 0.05% | 21,015 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 912,197 | Institution | 2.39% | 1,012,539 | |
| 321,840 | Institution | 0.84% | 357,242 | |
| 111,200 | Institution | 0.29% | 123,432 | |
| 50,695 | Institution | 0.13% | 56,271 | |
| 28,500 | Institution | 0.07% | 31,635 | |
| 18,932 | Institution | 0.05% | 21,015 | |
| 5,286 | Institution | 0.01% | 5,867 | |
| 3,417 | Institution | <0.01% | 3,793 | |
| 1,138 | Institution | <0.01% | 1,263 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 846,561 | Institution | 2.22% | 1,185,185 | |
| 172,110 | Institution | 0.45% | 240,954 | |
| 56,323 | Institution | 0.15% | 62,519 | |
| 56,143 | Institution | 0.15% | 62,319 |
FAQ
Who Owns Bolt Biotherapeutics (BOLT)?
According to the latest TipRanks data, approximately 12.20% of the company's stock is held by institutional investors, 43.52% is held by insiders, and 40.46% is held by retail investors.
What percentage of Bolt Biotherapeutics (BOLT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.20% of Bolt Biotherapeutics (BOLT) stock is held by institutional investors.
What percentage of Bolt Biotherapeutics (BOLT) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.46% of Bolt Biotherapeutics (BOLT) stock is held by retail investors.
Who owns the most shares of Bolt Biotherapeutics (BOLT)?
Vanguard owns the most shares of Bolt Biotherapeutics (BOLT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.